Navigation Links
CPhI Japan, ICSE Japan, P-MEC Japan, BioPh Japan, and Pharmatec Japan Exhibitions Open Doors to Japan's US$90 Billion Pharmaceutical Market
Date:4/23/2013

rgently seeking to secure new and reliable suppliers of price-competitive and high-quality pharmaceutical ingredients. This trend provides lucrative new business opportunities to international API suppliers around the world and is one of the reasons why international exhibitors at CPhI Japan, particularly from South Korea, China, and India, have continued to increase over the past ten years.

The high yen and intense price competition makes it difficult for Japanese API manufacturers to compete with overseas players, even in their own domestic market. On the other hand, product quality and safety control is the paramount priority for Japanese pharmaceutical manufacturers; thus, suppliers cannot sell their products in the Japanese market purely based on price. Recent instances of overseas suppliers of APIs for generic drugs with failed inspections from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)'s GMP inspection has led Japanese generic drug manufacturers having to suspend production of some products due to a lack of ingredients.

As a result, Japanese pharmaceutical manufacturers and traders are very eager to find API suppliers who can provide them with API that are not only competitively priced but are also reliable and of high quality. Stable supply is very important to be successful in Japan.

Seminar sessions at CPhI Japan that explain the inner workings of Japan's Pharmaceutical Affairs Law (PAL) are always oversubscribed. In particular, the session entitled "Explanation and Case Study for Japan Pharmaceutical Affairs Law held in English" has been one of the most popular sessions for overseas participants for the past several years. This year, partly due to the incidents mentioned above, it was fully subscribed shortly after it was announced on the website.

The seminars are given by lecturers from the PMDA an
'/>"/>

SOURCE UBM Asia
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rutgers Business School and the Blanche and Irwin Lerner Center will explore trends and issues facing the biopharmaceutical industry at a healthcare symposium, Tuesday, April 30
2. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
3. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
4. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
5. Comparison of Biopharmaceutical Industry Between China and India 2013
6. Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients
7. TransCelerate BioPharma Inc. Grows, Strengthens Novel Effort to Accelerate Drug Development
8. Biopharmaceutical Companies Transform Clinical Trial Strategies for Success in Global Marketplace
9. Americas Biopharmaceutical Companies Commitment to Research Remains Strong Despite Challenges
10. Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
11. In Q1 Public Biopharmas Shift Fundraising into Overdrive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... 2014 The Cadence Fitness & Health Center has ... Medical Fitness Association, a non-profit organization assisting medically integrated ... The Cadence Fitness & Health Center is the only ... in the Chicagoland area. "The certification means ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... MEDomics, LLC provides NextGen sequence-based DNA diagnostic ... era and is transforming diagnostic testing for mitochondrial ... capital investment from our partner, SpaGus Ventures LLC. ... used by MEDomics to fuel the continued growth ...
... FLORHAM PARK, N.J., April 7, 2011 Shionogi Inc., ... today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) ... reduce chronic severe drooling in patients aged 3 to ... as cerebral palsy. "Shionogi is proud ...
Cached Medicine Technology:MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer 2Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 2Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 3Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 4Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 5
(Date:4/24/2014)... at the University of York reveals that a process ... the nervous system may also play a pivotal role ... team, led by Dr Will Brackenbury, a Medical Research ... has studied how voltage-gated sodium channels assist in the ... the membranes of excitable cells, such as neurons, where ...
(Date:4/23/2014)... stool from healthy, unrelated donors was safe and ... caused by Clostridium difficile , according to ... Infectious Diseases and available online. Known as ... whether given via a colonoscope or a nasogastric ... this promising treatment more readily available to patients. ...
(Date:4/23/2014)... researchers say clinical trials for a new experimental ... very promising. Patients treated with CPX-351, a combination ... showing better responses than patients treated with the ... myeloid leukemia is an aggressive blood cancer with ... older patients," explained Jeffrey Lancet, M.D., senior member ...
(Date:4/23/2014)... M.D., scientific director at the National Institute of Arthritis ... the 2014 recipient of the Ross Prize in Molecular ... Molecular Medicine . The award will be given ... Sciences in Manhattan, followed by scientific presentations by Dr. ... the National Institutes of Health. , The award, which ...
(Date:4/23/2014)... 2014 The American Society for Radiation Oncology (ASTRO) ... Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO ... radiation therapy in the treatment of endometrial cancer. ... May-June 2014 issue of Practical Radiation Oncology ... ASTRO. The full-length guideline is available as an ...
Breaking Medicine News(10 mins):Health News:Breast cancer replicates brain development process 2Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3
... To reduce mortality and improve patient care in the ... Care Societies Collaborative (CCSC), in conjunction with the US ... that research in the field become less fragmented and ... critical illness. The CCSC comprises the ...
... a popular activity in nursing homes, senior centers ... beyond socializing. Researchers found high-contrast, large bingo cards ... cognitive difficulties and visual perception problems produced by ... "The general finding of improved performance across healthy ...
... Michigan State University researchers one working at a medieval ... in East Lansing have shown how modern science can ... the first to confirm the existence of brucellosis, an infectious ... The findings, which appear in the American Journal of ...
... best cigarette is no cigarette, but for the millions ... researchers from Cornell University may have found a way ... antioxidant extracts in cigarette filters, the researchers were able ... reduced the amount of cancer-causing free radicals passing through ...
... suggests that there may be a positive relationship between ... to a report in the January issue of ... the JAMA/Archives journals. Amika Singh, Ph.D., of the ... and Care Research, Amsterdam, the Netherlands, and colleagues reviewed ...
... , SUNDAY, Jan. 1 (HealthDay News) -- Losing weight is ... long-held behaviors is a skill in itself, a medical expert ... people have to be ready to face some setbacks and ... and medical weight-loss specialist at Gottlieb Memorial Hospital, part of ...
Cached Medicine News:Health News:ATS issues joint statement on key issues and recommendations for critical care research 2Health News:ATS issues joint statement on key issues and recommendations for critical care research 3Health News:'BINGO!' game helps researchers study perception deficits 2Health News:Scientists crack medieval bone code 2Health News:Physical activity, school performance may be linked 2Health News:Persistence Is Key to Losing Weight and Keeping It Off 2Health News:Persistence Is Key to Losing Weight and Keeping It Off 3
... The Vitros ECi brings true ... to immunodiagnostic testing. Highly sensitive assays ... oncology and bone metabolism testing are ... under development. The Vitros ECi can ...
... is a flexible system that ... environments small hospitals, backup ... satellite locations. The Vitros 250 ... can be automated or placed ...
... an effort to improve on the ... toxicology, abused drugs, and immunosuppressants tests, ... which incorporates random access capabilities. Although ... undergone several important changes in the ...
The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
Medicine Products: